FDA NDC Directory · JSON-LD · Markdown

Increlex

NDC 71863-216 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameMecasermin
Labeler / ManufacturerEton Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA021839
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsMECASERMIN (40 mg/4mL)
Marketing started20250416
Package count1

External sources

Source: openFDA. Public-domain (CC0).